Malta - English - Malta Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - vi polysaccharide, of salmonella, typhi - solution for injection - vi polysaccharide of salmonella typhi 25 µg - vaccines

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - salmonella typhi vi polysaccharide 25ug - solution for injection - 25µg/0.5ml - active: salmonella typhi vi polysaccharide 25ug excipient: dibasic sodium phosphate hydrochloric acid monobasic sodium phosphate dihydrate phenol sodium chloride sodium hydroxide water for injection - typhim vi™ is indicated for active immunisation against typhoid fever caused by salmonella typhi in individuals 2 years of age and over.

Israel - English - Ministry of Health

sanofi israel ltd - purified vi capsular polysaccharide of s.typhi - solution for injection - purified vi capsular polysaccharide of s.typhi 0.025 mg / 0.5 ml - typhoid, purified polysaccharide antigen - typhoid, purified polysaccharide antigen - typhim vi vaccine is indicated for active immunization against typhoid fever for persons two years of age or older.

Malta - English - Malta Medicines Authority

jv healthcare limited - vi polysaccharide, of salmonella, typhi - solution for injection - vi polysaccharide of salmonella typhi 25 microgram(s) - vaccines

United States - English - NLM (National Library of Medicine)

sanofi pasteur inc. - salmonella typhi ty2 vi polysaccharide antigen (unii: 7194h8w3kt) (salmonella typhi ty2 vi polysaccharide antigen - unii:7194h8w3kt) - salmonella typhi ty2 vi polysaccharide antigen 25 ug in 0.5 ml - typhim vi vaccine is indicated for active immunization for the prevention of typhoid fever caused by s typhi and is approved for use in persons two years of age or older. immunization with typhim vi vaccine should occur at least two weeks prior to expected exposure to s typhi . typhim vi vaccine is not indicated for routine immunization of individuals in the united states (us). (14) selective immunization against typhoid fever is recommended under the following circumstances: 1) travelers to areas where a recognized risk of exposure to typhoid exists, particularly ones who will have prolonged exposure to potentially contaminated food and water, 2) persons with intimate exposure (ie, continued household contact) to a documented typhoid carrier, and 3) workers in microbiology laboratories who frequently work with s typhi . (14) typhoid vaccination is not required for international travel, but is recommended for travelers to such areas as africa, asia, and central and south america where there is a recognized r

United States - English - NLM (National Library of Medicine)

virtus pharmaceuticals - vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t, retinol - unii:g2sh0xkk91), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol, d- (unii: n9pr3490h9) (.alpha.-tocopherol, d- - unii:n9pr3490h9), thiamine (unii: x66nso3n35) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyri - vitamin a 2500 [iu] - vp-pnv-dha is a prescription regimen of prenatal multi-vitamin, multi-mineral, and omega-3 fatty acid supplements and should be administered under the supervision of a licensed medical practitioner.

United States - English - NLM (National Library of Medicine)

virtus pharmaceuticals - cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol succinate, d- (unii: lu4b53jyve) (.alpha.-tocopherol, d- - unii:n9pr3490h9), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanoc - cholecalciferol 400 [iu] - vp-heme ob is contraindicated in patients with a known hypersensitivity to any of its ingredients.

United States - English - NLM (National Library of Medicine)

vi-jon, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 21 mg in 1 ml - acne medication for the treatment of acne

United States - English - NLM (National Library of Medicine)

virtus pharmaceuticals - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), biotin (unii: 6so6u10h04) (b - ascorbic acid 60 mg - vp-vite rx is indicated for the supplemental requirements of persons with nutritional deficiencies or those who are in need of nutritional supplementation. this product is contraindicated in persons with a known hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

vi-jon, llc - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - isopropyl alcohol 70 l in 100 l - first aid antiseptic first aid to help prevent the risk of infection in: - minor cuts - scrapes - burns for deep or puncutre wounds, animal bites or serious burns if condition persists or gets worse